A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside.
Aged
Decision Support Techniques
Diagnosis, Differential
Electrocardiography
Female
Humans
Middle Aged
New Zealand
Non-ST Elevated Myocardial Infarction
/ diagnosis
Patient Admission
Point-of-Care Testing
Predictive Value of Tests
Prognosis
Prospective Studies
Reproducibility of Results
Risk Factors
Sex Factors
Takotsubo Cardiomyopathy
/ diagnosis
Time Factors
non-ST segment elevation myocardial infarction
takotsubo syndrome
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
10
2019
revised:
02
01
2020
accepted:
03
02
2020
entrez:
24
3
2020
pubmed:
24
3
2020
medline:
24
3
2020
Statut:
epublish
Résumé
A score to distinguish Takotsubo syndrome (TS) from acute coronary syndrome would be useful to facilitate appropriate patient investigation and management. This study sought to derive and validate a simple score using demographic, clinical and ECG data to distinguish women with non-ST elevation myocardial infarction (NSTEMI) from NSTE-TS. The derivation cohort consisted of women with NSTE-TS (n=100) and NSTEMI (n=100). Logistic regression was used to derive the score using ECG values available on the postacute ward round on day 1 post-hospital admission. The score was then temporally validated in subsequent consecutive patients with NSTE-TS (n=40) and NSTEMI (n=70). The five variables in the score and their relative weights were: T-wave inversion in ≥6 leads (+3), recent stress (+2), diabetes (-1), prior cardiovascular disease (-2) and ST-depression in any lead (-3). When calculated using ECG values obtained at admission, discrimination between conditions was very good (area under the curve (AUC) 0.87 95% CI 0.83 to 0.92). The optimal score cut-point of ≥1 to predict NSTE-TS had 73% sensitivity and 90% specificity. When applied to the validation cohort at admission, AUC was 0.82 (95% CI 0.75 to 0.90) and positive and negative predictive values were 78% and 81%, respectively. On day 1 post-admission, AUC was 0.92 (95% CI 0.87 to 0.97), with positive and negative predictive values of 77% and 91%, respectively. This NSTE-TS score is easy to use and may prove useful in clinical practice to distinguish women with NSTE-TS from NSTEMI. Further validation in external cohorts is needed.
Identifiants
pubmed: 32201588
doi: 10.1136/openhrt-2019-001197
pii: openhrt-2019-001197
pmc: PMC7066633
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Pagination
e001197Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Cardiology. 2012;121(4):228-36
pubmed: 22555306
Circulation. 2005 Feb 1;111(4):472-9
pubmed: 15687136
J Am Coll Cardiol. 2010 Feb 16;55(7):700-1
pubmed: 20170799
Am Heart J. 2008 Sep;156(3):543-8
pubmed: 18760139
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Nov;40(11):897-901
pubmed: 23363668
Int J Cardiol. 2011 Jan 21;146(2):256-8
pubmed: 21111497
Int J Cardiol. 2013 Jul 1;166(3):584-8
pubmed: 22192296
Am Heart J. 2008 Mar;155(3):408-17
pubmed: 18294473
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Heart. 2009 Feb;95(2):125-9
pubmed: 18381374
Intern Med. 2002 Oct;41(10):789-92
pubmed: 12412997
Circulation. 1998 May 12;97(18):1837-47
pubmed: 9603539
Heart Fail Clin. 2013 Apr;9(2):249-66, x
pubmed: 23562126
Eur Heart J. 2018 Jun 7;39(22):2032-2046
pubmed: 29850871
Eur Heart J. 1994 Nov;15(11):1571-84
pubmed: 7835374
Am J Cardiol. 2013 Aug 15;112(4):479-82
pubmed: 23683950
Circ J. 2003 Aug;67(8):687-90
pubmed: 12890911
J Am Coll Cardiol. 2017 Feb 7;69(5):570-591
pubmed: 28012615
N Z Med J. 2013 Dec 13;126(1387):69-80
pubmed: 24362735
Am J Cardiol. 2004 Aug 1;94(3):343-6
pubmed: 15276100
Eur J Heart Fail. 2017 Aug;19(8):1036-1042
pubmed: 27928880
Eur Heart J. 2016 Jan 14;37(3):267-315
pubmed: 26320110
Int J Cardiol. 2015 Nov 15;199:132-40
pubmed: 26188834
Am Heart J. 2009 May;157(5):933-8
pubmed: 19376324
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Am J Cardiol. 2008 Jun 15;101(12):1723-8
pubmed: 18549847
Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S89-100
pubmed: 9820468
JAMA Cardiol. 2016 Jun 1;1(3):335-40
pubmed: 27438117
Biom J. 2005 Aug;47(4):458-72
pubmed: 16161804
Am J Cardiol. 2003 Jul 15;92(2):230-3
pubmed: 12860233
J Am Coll Cardiol. 2007 Aug 14;50(7):647-9
pubmed: 17692751
Am J Cardiol. 2007 Jan 15;99(2):182-5
pubmed: 17223415
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Aust N Z J Public Health. 2014 Jun;38(3):216-20
pubmed: 24890478